Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.32 | 5e-06 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |